AMR Review Releases Final RecommendationsUrging New Investments to Prevent a Catastrophic Rise of MDR-TB
Rapid diagnostic tests, shorter treatmentTB programmes must now scale up to treat and cure all MDR-TB patients
GDF announces a 70% reduction for linezolidThis is projected to save up to US$30 million over the next 3 years.
TB & HIV Advocates Call for Joint ActionTB & HIV communities joined together UN headquarters in New York
The Global Plan to End TB 2016-2020provides a roadmap for the fight against TB for a five-year period.
19 May - AMR Review Releases Final Recommendations Urging New Investments to...AMR Review Releases Final Recommendations Urging New Investments to Prevent a Catastrophic Rise of Drug-Resistant Tuberculosis and other Infections
19 May 2016, Geneva, Switzerland - The final recommendations of the Review on Antimicrobial Resistance (AMR) led by Lord Jim O’Neill and commissioned by UK Prime Minister David Cameron were released today, warning that AMR infections such as drug-resistant tuberculosis will kill 10 million people annually without an urgent expansion of new resources and funds.
16 May - Leave no one behind: Stop TB Partnership launches seven key population...Leave no one behind: Stop TB Partnership launches seven key population briefs
16 May 2016 - Geneva, Switzerland - The Stop TB Partnership today launched a eries of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic.
13 May - Rapid diagnostic tests, shorter treatment: TB programmes now must scale up...Rapid diagnostic tests, shorter treatment: TB programmes now must scale up to treat and cure all people affected by MDR-TB
13 May 2016 - Geneva, Switzerland - The TB community welcomes the new WHO recommendations that aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper regimen.
12 May - In honor of the dedication, commitment and tireless efforts of nurses...In honor of the dedication, commitment and tireless efforts of nurses: celebrating International Nurses Day
12 May 2016 Geneva, Switzerland - Globally, nurses make up the largest cadre of health care providers. In most parts of the world, a person affected by TB will never see a doctor -- all care is provided by a nurse from diagnosis to treatment completion.
29 April - Meet the new Challenge Facility for Civil Society grantees!Meet the new Challenge Facility for Civil Society grantees!
29 April 2016, Geneva, Switzerland - The Stop TB Partnership’s Global Plan to Stop TB 2016-2020, challenges the traditional biomedical approaches to TB and calls for integrated and comprehensive responses to TB that are patient-centered and include strong partnerships with communities and civil society. To support community engagement the Stop TB Partnership launched a call for the seventh round of Challenge Facility for Civil Society (CFCS) grants in 2015. The CFCS provides grants to technically sound and innovative interventions to support the engagement of communities in national tuberculosis (TB) responses.
29 April - Stop TB Partnership's first ever Capacity Building Workshop with civil...Stop TB Partnership's first ever Capacity Building Workshop with civil society on procurement and supply chain management
29 April 2016 - The Stop TB Partnership this month, for the first time, organized a workshop specifically aimed to help civil society representatives from a selected group of countries better under-stand procurement and supply chain management (PSM) in order to increase access to TB drugs, diagnostics and other commodities. Experience has proven that a broad cooperation with commu-nities and civil society leads to more accurate data, which in turn increases accountability in pro-curement and supply chain management.
28 April - Stop TB Partnership's Global Drug Facility announces a 70% price reduction...Stop TB Partnership's Global Drug Facility announces a 70% price reduction for linezolid: another critical step towards achieving equitable access to MDR-TB treatment
28 April 2016 - Geneva, Switzerland - In another landmark achievement, the Global Drug Facility (GDF) of the Stop TB Partnership, has announced that the price of linezolid - a key medicine used to treat multidrug-resistant tuberculosis (MDR-TB) - will be cut by approximately 70% in 2016 compared to the previous year. This significant price reduction is projected to save up to US$ 30 million over the next 3 years, bringing us one step closer to making crucial MDR-TB medicines accessible to people that need them the most.
April 28 2016
April 27 2016
April 26 2016
March 24 2016
We set goals to fight TB globally. We grant funds to reach and treat people living with TB. We strive to raise the profile and understanding of TB. We bring the voice of TB communities to the fore. We procure drugs and diagnostics.
We work together with our partners to create a world without TB.
We are the Stop TB Partnership.